As of June 16, 2025, DiaSys Corp (DYXC) reports a Net Margin of -46.78%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of DiaSys Corp's Net Margin
Over recent years, DiaSys Corp's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2007-06-30 | -46.78% |
| 2006-06-30 | -62.09% |
| 2005-06-30 | -106.06% |
| 2004-06-30 | -160.28% |
| 2003-06-30 | -59.79% |
This steady improvement highlights how DiaSys Corp manages its overall profitability and cost control over time.
Comparing DiaSys Corp's Net Margin to Peers
To better understand DiaSys Corp's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| DiaSys Corp (DYXC) | -46.78% |
| PAVmed Inc (PAVM) | 1328.58% |
| Hypertension Diagnostics Inc (HDII) | -3.31% |
| Hemagen Diagnostics Inc (HMGN) | -22.45% |
| American Medical Technologies Inc (ADLI) | -29.08% |
| Nexeon Medsystems Inc (NXNN) | -65.93% |
Compared to its competitors, DiaSys Corp's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.